by Heather Smith Thomas, published in SPEEDHORSE, July 2022 issue.
Research trials are beginning to assess a new process for treating multidrug-resistant bacterial joint infections (septic arthritis) in foals. This research is a partnership between Colorado State University, Ontario Veterinary College in Guelph and Rood and Riddle Equine Hospital in Kentucky. Dr. Thomas Koch (Department of Biomedical Sciences, Ontario Veterinary College), founder and CEO of eQcell, has co-authored several papers discussing early research looking at combining antibiotics and stem cells in treating these resistant infections. Mesenchymal stromal cells (MSCs) are being used with antibiotics with good results.... Read the complete interview for Speedhorse here.
